Psoriasis, psoriatic arthritis research makes headway at GRAPPA meetingAugust 10, 2017Psoriatic ArthritisPsoriasis
Study finds secukinumab effective for moderate to severe scalp psoriasisAugust 9, 2017PsoriasisPsoriatic Arthritis
First interchangeability study for an adalimumab biosimilar has begunJuly 31, 2017PsoriasisPsoriatic Arthritis
Children with psoriasis face multitude of comorbiditiesJuly 15, 2017PsoriasisPediatricsPsoriatic Arthritis
First IL-23 blocker, guselkumab, earns FDA approval for psoriasisJuly 13, 2017PsoriasisPsoriatic Arthritis
Early phase III data positive for adalimumab biosimilar, for both psoriasis and PsAJuly 1, 2017Psoriatic ArthritisPsoriasis
Ustekinumab trumps TNF-blockade for enthesitis in patients with psoriatic arthritisJune 17, 2017Psoriatic Arthritis
_web.jpg)
